EUPRAXIA PHARMACEUTICALS INC.

Insiders Eupraxia Pharmaceuticals Inc.

Equities

EPRX

CA29842P1053

Delayed Toronto S.E. Other stock markets 04:00:00 2024-07-15 pm EDT			5-day change	1st Jan Change
3.68 ^CAD	-0.54%		+5.75%	-31.47%

Jul. 03	Eupraxia Pharmaceuticals Inc. Brief: Says CEO Dr. James Helliwell to Participate in Webinar Event, 'Exploring the Rapid Rise of Osteoarthritis' on July 9, 2024	MT
Jun. 05	Eupraxia Pharmaceuticals Inc. Brief: Says To Present Data from the Phase 2 SPRINGBOARD Study in Osteoarthritis of the Knee at EULAR European Congress of Rheumatology 2024	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eupraxia Pharmaceuticals Inc. Brief: Says CEO Dr. James Helliwell to Participate in Webinar Event, 'Exploring the Rapid Rise of Osteoarthritis' on July 9, 2024	Jul. 03	MT
Eupraxia Pharmaceuticals Forms Gastrointestinal Clinical Advisory Board	May. 02	MT
Eupraxia Pharmaceuticals Inc. Appoints Mark Kowalski as Chief Medical Officer	23-05-18	CI
Eupraxia Pharmaceuticals Inc. Brief: Appointing Mark Kowalski, MD, PhD, as Company's Chief Medical Officer, effective May 18, 2023	23-05-18	MT
Eupraxia Pharmaceuticals Inc. Appoints Industry Veteran, Paul Brennan, As Chief Business Officer	22-11-01	MT
Eupraxia Pharmaceuticals Appoints Paul Brennan to Chief Business Officer	22-11-01	CI
Eupraxia Pharmaceuticals Inc. Elects Richard M. Glickman to Board of Directors	21-12-03	CI
Eupraxia Pharmaceuticals Inc. Appoints Bruce Cousins as New President, Effective May 3, 2021	21-05-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer